Financhill
Buy
75

DNTH Quote, Financials, Valuation and Earnings

Last price:
$44.76
Seasonality move :
32.46%
Day range:
$38.95 - $46.22
52-week range:
$13.37 - $46.22
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
526.28x
P/B ratio:
3.52x
Volume:
1.7M
Avg. volume:
692.8K
1-year change:
94.7%
Market cap:
$1.9B
Revenue:
$6.2M
EPS (TTM):
-$3.49

Earnings Data

Next earnings date for DNTH
Mar 10
2026
Most recent earnings per share
-$0.97
Missed by $0.07
(Nov 5/2025)
Consensus Estimate
-$0.90
(Nov 5/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

DNTH Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
03/31/2026 Q1 $199.4K -- -- -$1.03 --
03/10/2026 Q4 $398.1K -- -- -$1.04 --
11/05/2025 Q3 $523.6K $396K -$0.97 -$0.90 -$0.07
08/08/2025 Q2 $864.7K $193K -$0.88 -$0.87 -$0.02
05/08/2025 Q1 $806.9K $1.2M -$0.82 -$0.71 -$0.11
03/11/2025 Q4 $859.7K $1.3M -$0.81 -$0.76 -$0.05
11/07/2024 Q3 $576.4K $2.2M -$0.74 -- --
08/08/2024 Q2 $322.8K $1.9M -$0.51 -- --
05/09/2024 Q1 $371.4K $874K -$0.54 -- --
03/21/2024 Q4 $438.8K $457K -$0.71 -- --
11/09/2023 Q3 $250K $924K -$3.78 -- --
06/30/2023 Q2 -- $969K -$12.73 -- --
03/31/2023 Q1 -- $476K -$129.67 -- --
12/31/2022 Q4 -- $1.2M -$11.57 -- --
09/30/2022 Q3 -- $1.2M -$142.45 -- --
06/30/2022 Q2 -- -- -$4.70 -- --
03/31/2022 Q1 -- -- -$6.25 -- --
12/31/2021 Q4 -- -- -$5.25 -- --
09/30/2021 Q3 -- -- -$4.76 -- --
06/30/2021 Q2 -- -- -$5.04 -- --
03/31/2021 Q1 -- -- -$5.76 -- --
12/31/2020 Q4 -- -- -$5.99 -- --
09/30/2020 Q3 -- -- -$5.86 -- --
06/30/2020 Q2 -- -- -$7.71 -- --
03/31/2020 Q1 -- -- -$8.13 -- --
12/31/2019 Q4 -- -- -$9.52 -- --
09/30/2019 Q3 -- -- -$8.65 -- --
06/30/2019 Q2 -- -- -$7.73 -- --
03/31/2019 Q1 -- -- -$7.10 -- --
12/31/2018 Q4 -- -- -$8.04 -- --
09/30/2018 Q3 -- -- -$7.77 -- --
06/30/2018 Q2 -- -- -$50.09 -- --
03/31/2018 Q1 -- -- -$5.05 -- --
09/30/2017 Q3 -- -- -$3.13 -- --
06/30/2017 Q2 -- -- -$6.96 -- --
03/31/2017 Q1 -- -- -$2.34 -- --

Dianthus Therapeutics, Inc. Earnings Questions

  • How Much did Dianthus Therapeutics, Inc. Generate in Revenue Last Quarter?

    Dianthus Therapeutics, Inc. reported $396K worth of top line sales in its most recent quarter.

  • Did Dianthus Therapeutics, Inc. Beat Earnings Last Quarter?

    Dianthus Therapeutics, Inc. announced earnings per share of -$0.97 which represents a miss of analyst forecast a -$0.90 per share.

  • Is Dianthus Therapeutics, Inc. Profitable?

    Dianthus Therapeutics, Inc. reported $297K that represents $0.01 per share over the last quarter.

  • What is the Analyst Consensus for Dianthus Therapeutics, Inc. EPS Next Year?

    Dianthus Therapeutics, Inc.'s earnings are forecast to decrease from -$2.55 per share to -$3.73 per share next year representing a decrease of -51.66%.

  • When is Dianthus Therapeutics, Inc.'s Earnings Date?

    Dianthus Therapeutics, Inc.'s next earnings date is March 10, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Is Amkor Stock Up So Much?
Why Is Amkor Stock Up So Much?

Semiconductor packaging and testing major Amkor (NASDAQ:AMKR) has started 2026…

Is Shopify Stock a Good Buy Now?
Is Shopify Stock a Good Buy Now?

eCommerce technology platform Shopify (NASDAQ:SHOP) delivered impressive returns in 2025…

Will The Magnificent 7 Stocks Go Up This Year?
Will The Magnificent 7 Stocks Go Up This Year?

2025 was another banner year for the Magnificent Seven stocks,…

Stock Ideas

Buy
54
Is NVDA Stock a Buy?

Market Cap: $4.5T
P/E Ratio: 63x

Buy
67
Is GOOG Stock a Buy?

Market Cap: $4.1T
P/E Ratio: 42x

Buy
53
Is GOOGL Stock a Buy?

Market Cap: $4.1T
P/E Ratio: 42x

Alerts

Sell
49
RGC alert for Jan 14

Regencell Bioscience Holdings Ltd. [RGC] is down 25.71% over the past day.

Buy
89
TTMI alert for Jan 14

TTM Technologies, Inc. [TTMI] is up 19.75% over the past day.

Sell
49
MRNA alert for Jan 14

Moderna, Inc. [MRNA] is up 17.08% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock